A coherent consensus regarding the etiology of multiple sclerosis (MS) and immune-mediated chronic diseases (such as rheumatoid arthritis, juvenile diabetes, and autoimmune thyroid disease) has emerged over the past two decades: exogenous (including infectious), environmental, or behavioral (lifestyle) factors cause disease onset in genetically susceptible persons. 1 Neither genes by themselves nor exogenous factors alone are sufficient to cause MS. The likely scenario is that, in a genetically susceptible person, the equilibrium among components of the trimolecular complex (major histocompatibility complex molecules, T-cell receptors, and foreign or self antigens) is disrupted sufficiently to induce a chronic state of autoimmune damage. 2 Despite theories, however, no infectious agent has been established as a causal agent in MS. An environmental etiology for MS is suggested by the strong north-south gradient in disease frequency, by disease clusters, and by evidence that migration to and from high-risk areas in early life influences the likelihood of developing MS.
More sophisticated investigations regarding lifestyle factors associated with MS have recently emerged. Smoking appears to have important but modest associations with MS and other autoimmune disorders; the basis for this association is not yet clear. Riise et al., in this issue of Neurology, identified a nearly twofold risk of developing MS in ever smokers in a population-based study of prevalent cases of MS from one region in Norway. 3 Importantly, this risk was not substantially reduced when an indirect measure (education level) of socioeconomic status was included in multivariate modeling. Very similar increased risks have been reported in four other population-based studies (table) . [4] [5] [6] [7] The magnitude of the associations with cigarette smoking has been modest, but in addition to an association with having ever smoked, several studies appear to support a dose-response relationship between smoking and MS. These four studies used incident rather than prevalent cases of MS, thus reducing potential bias concerning the timing of exposure and its relationship to the timing of disease onset. Tar and nicotine may be important immunotoxic components in cigarette smoke. 8 Both the smoke itself, as well as nicotine, may impair antigen-mediated signaling in T cells. 9 Smoking has been associated with other immune-mediated disorders, including rheumatoid arthritis. 10 Beyond smoking, diet has also been a behavioral risk factor of interest since two early ecologic studies suggested an association between high fish intake and lowered risk of MS 11 and between high animal fat-based caloric intake and increased risk of MS. 12 Whether specific components of diet can alter risk for developing any chronic disease is extremely difficult to study. Retrospectively collected dietary history for intake patterns that occurred 10 to 20 years prior to disease onset may be plagued by imprecise recall. Increased linoleic acid intake, but not other specific fat sources, has been associated with lower MS risk (RR ϭ 0.3, 95% CI 0.1 to 1.1) in a prospective cohort study. 13 Linoleic acid supplementation can also lessen the severity of experimental allergic encephalomyelitis in guinea pigs.
14 Vitamin D has also been considered as a potential risk factor. The latitude effect on MS prevalence may be related to decreasing gradients of sunlight and decreased production of vitamin D. There is strong correlation between regional MS prevalence and ultraviolet radiation levels in Australia. 15 Vitamin D can completely inhibit induction of experimental allergic encephalomyelitis in mice, perhaps by stimulating anti-encephalitogenic cytokines. 16 Finally, vitamin D receptor (the site of vitamin D action) gene polymorphisms are associated with MS in Jap-anese 17 but not in Canadian 18 patients. Ongoing work associating vitamin D exposure, ultraviolet irradiation, and MS is under way in Australia, as is research examining dietary vitamin D supplementation as a possible preventive treatment strategy for the disease.
An association between solvent exposure and MS has been reported in some studies, but more recently, no increase in MS incidence was found following organic solvent exposure. 19, 20 The risk of developing MS is not established to be affected by other exogenous factors such as physical trauma, vaccinations, or stressful life events.
The environmental factors of most interest to people with MS are modifiable factors that may trigger disease exacerbations. The role of environmental factors in the prognosis of MS has been largely limited to investigations of viral infections and physical trauma as triggers of disease exacerbations. Prospective studies among patients with MS have consistently shown a relationship between viral infections and exacerbations of MS, including a recent study showing a twofold increased risk of clinical relapses following symptomatic upper respiratory tract infections and a 3.4-fold increased risk of exacerbation among those with raised antiviral antibody titres. 21 Despite speculation, credible epidemiologic studies have not shown that physical trauma is a disease trigger. 22 The quality of life for persons with MS and other chronic diseases is dependent on their perceived ability to maintain autonomy and control. 23 Unproven expensive (removal of mercury amalgam), potentially harmful (e.g., some herbs, large doses of vitamins A or D), or burdensome (gluten-free diet) treatments should be avoided. Smoking, on the other hand, has been associated with transient symptomatic worsening, 24 and randomized trial data have suggested a beneficial effect of polyunsaturated fatty acid intake on rate of MS exacerbations. 25, 26 Smoking cessation and eating a diet low in animal fat and rich in polyunsaturated fatty acids and vitamin D foods may be encouraged. 
